Multimillion-dollar initiative will help bring safe biopharmaceutical products to market faster and develop workforce training programs for the biopharmaceutical field.

Researchers from academia, government, and industry examine both established and emerging techniques to detect protein aggregation in biologic drug products.

Director of the School’s Pharmaceutical Research Computing (PRC) center honored for her “can-do” attitude and efforts to streamline center processes.

Drs. Nicole Brandt, Linda Simoni-Wastila, and Chanel Whittaker will continue the Center’s legacy of improving drug therapy for older adults.

Presentations delivered by leaders across academia and industry highlight new methods and approaches to drug design that attendees can apply in their laboratories.

Researchers across academia, government, and industry explore how real world evidence can be harnessed to create a national evaluation system and improve the safety and effectiveness of medical devices.

FDA praises the Center’s efforts to bring academic, government, and industry stakeholders together for collaborative project with wide-reaching implications.

Award honors pharmacy practitioners who have demonstrated exceptional leadership in enhancing health care quality and medication use among patients throughout their careers.

Week-long workshop featured presentations, panel discussions, and other activities designed to broaden participants’ knowledge of comparative effectiveness research and patient-centered outcomes research.

More than 500 researchers from academia, government, and industry gather to gain perspective on biomarker development and the application of biomarkers in preclinical and clinical research.